Phoenix Biosciences, Inc. (PBS), focused on developing affordable, non-toxic treatments for HIV/AIDS, announced today that the U.S. Patent and trademark office has granted PBS Patent Number 6,734,192. This patent was provided to Phoenix Biosciences, Inc., for their novel immunological method, which claims to reduce HIV activity.
